SINDROM MILLER FISHER  SEBAGAI VARIAN SINDROM  GUILLAN BARRE :  LAPORAN KASUS

Lydia Susanti; Fadrian Herjunio

doi:10.59003/nhj.v2i12.973

Authors

Lydia Susanti Universitas Andalas
Fadrian Herjunio Universitas Andalas

DOI:

https://doi.org/10.59003/nhj.v2i12.973

Keywords:

Miller Fisher syndrome, ataxia, areflexes, ophthalmoplegia

Abstract

Miller Fisher syndrome (MFS) is a rare variant of Guillan Barre Syndrome (GBS), with clinical symptoms of ophthalmoplegia, ataxia, areflexia. The diagnosis of MFS in this patient is based on a clear history supported by supporting examinations such as electrophysiological examination and CSF analysis. CSF analysis is often unsupportive at the onset of the disease, in which case the validated Brighton criteria may serve as a reference for establishing the diagnosis of GBS and its variants.

Downloads

Download data is not yet available.

References

Ralapanawa U, Kumarihamy P, Jayalath T, Udupihille J. Guillain-Barré syndrome with associated unilateral ptosis without ophthalmoplegia - A rare presentation: A case report and review of the literature. J Med Case Rep. 2019;13(1):1–5.

Ropper AH, Samuels MA, Klein JP. Adams and Victor’s Principles of Neurology. 11th ed. McGraw-Hill Education. New York: McGraw-Hill education; 2019. 575 p.

De Castillo LLC, Diestro JDB, Ignacio KHD, Pasco PMD. A rare mimic of acute stroke: Rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome. BMJ Case Rep. 2019;12(3):12–5.

Pohl M, Hesszenberger D, Kapus K, Meszaros J, Feher A, Varadi I, et al. Ischemic stroke mimics: A comprehensive review. J Clin Neurosci [Internet]. 2021;93:174–82. Available from: https://doi.org/10.1016/ j.jocn.2021.09.025

Helen Hyun-Jin Do. Miller fisher syndrome mistaken as stroke in an octogenarian. 2009;57(1):186–7.

Hwang DY, Silva GS, Furie KL, Greer DM. Comparative sensitivity of computed tomography vs. magnetic resonance imaging for detecting acute posterior fossa infarct. J Emerg Med [Internet]. 2012;42(5):559–65. Available from: http://dx.doi.org/10.1016/j.jemermed.2011.05.101

Wakerley BR, Uncini A, Yuki N. Guillain-Barré and miller fisher syndromes New diagnostic classification. Nat Rev Neurol[Internet].2014;10(9):537–44.Availablefrom: http://dx.doi.org/10.1038/nrneurol.2014.138

Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56(8):1104–6.

Snyder LA, Rismondo V, Miller NR. The fisher variant of Guillain-Barré syndrome (fisher syndrome). J Neuro-Ophthalmology. 2009;29(4):312–24.

Berlit P RJ. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol. 1992;12:57–63.

Tham SL, Prasad K, Umapathi T. Guillain–Barré syndrome mimics. Brain Behav. 2018;8(5):1–5.

Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: A systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.

Swathy Chandrashekhar M, Mazen M Dimachkie M. Guillain-Barré syndrome in adults: Pathogenesis, clinical features, and diagnosis[Internet].uptodate.2022.Availablefrom:https://www.uptodate.com/contents/ guillain-barre-syndrome-in-adults-pathogenesis-clinical-features-and- diagnosis

Fokke C, Van Den Berg B, Drenthen J, Walgaard C, Van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(1):33–43.

Wakerley BR, Yuki N. Mimics and chameleons in guillain– barré and miller fisher syndromes. Pract Neurol. 2015;15(2):90–9.

Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004;148(1–2):200–5.

Anthony SA, Thurtell MJ, Leigh RJ. Miller fisher syndrome mimicking ocular myasthenia gravis. Optom Vis Sci. 2012;89(12):1–10.

Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle and Nerve. 2008;37(2):141–9.

Edlow JA, Newman-Toker DE, Savitz SI. Diagnosis and initial management of cerebellar infarction. Rev Neurol Argentina. 2009;1(2):160–1.

Rac H, Aa G, Pa D. Corticosteroids for Guillain-Barré syndrome (Review). 2016;Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, Péréon Y, et al. Current treatment practice of Guillain-Barré syndrome. Neurology. 2019;93(1):E59–76.